Orexigen Therapeutics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 87   

Articles published

OREX 2.99 -0.04 (-1.39%)
price chart
Orexigen Therapeutics Reports Financial Results for the First Quarter Ended ...
SAN DIEGO, May 9, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced business and financial results for the first quarter ended March 31, 2017.
Orexigen Therapeutics' (OREX) CEO Mike Narachi on Q1 2017 Results ...  Seeking Alpha
Are Analysts Downgrading Orexigen Therapeutics Inc.?  BBNS
Orexigen Therapeutics Launches "Brains Behind Weight Loss," a Dynamic Patient ...
SAN DIEGO, Jan. 3, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) unveiled "Brains Behind Weight Loss," a new, national direct-to-consumer advertising campaign demonstrating to patients how the brain plays an important role in weight ...
Orexigen Therapeutics Announces Commercialization and Distributorship ...
SAN DIEGO, Dec. 8, 2016 /PRNewswire/ -- Orexigen Therapeutics, Inc. (NASDAQ: OREX) today announced that its wholly owned subsidiary Orexigen Therapeutics Ireland Ltd.
Orexigen Therapeutics to Provide Business Update at the 2017 Bank of America ...
SAN DIEGO, May 2, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) announced today that management will present at the 2017 Bank of America Merrill Lynch Healthcare Conference on Tuesday, May 16th, at 4:20 PM PDT (7:20 PM EDT).
Orexigen Therapeutics, Inc. (OREX) Sees Significant Decline in Short Interest  The Cerbat Gem
A Look at 2 Trending Stocks: Shopify Inc. (SHOP), Orexigen Therapeutics, Inc ...  Post Analyst
Orexigen Therapeutics to Provide Business Update and Discuss First Quarter ...
SAN DIEGO, April 25, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (NASDAQ: OREX) will announce corporate and financial results for the first quarter 2017 on Tuesday, May 9th after the market closes. Following the announcement, Orexigen will ...
Traders Take Note: Orexigen Therapeutics Inc (NASDAQ:OREX) Stock Drops ...
Take Note: Orexigen Therapeutics Inc (NASDAQ:OREX) has hit some technical weakness in its momentum, and while it has not broken down all the way through support -- watch the key levels that we discuss below and further, watch the stochastics and ...
Orexigen Therapeutics, Inc. (OREX) Releases Earnings Results, Misses ...  BBNS
Zacks: Analysts Anticipate Orexigen Therapeutics, Inc. (OREX) Will Post ...  Transcript Daily
Successful Earnings Option Trading: Orexigen Therapeutics Inc (NASDAQ:OREX)
As we look at Orexigen Therapeutics Inc we note that a short put is one of the most common implementations of an option strategy, but the analysis completed when employing the short put often times lacks the necessary rigor especially surrounding earnings.
Orexigen Therapeutics Announces Commercialization and Distributorship ...
SAN DIEGO, Dec. 19, 2016 /PRNewswire/ -- Orexigen Therapeutics, Inc. (NASDAQ: OREX) today announced that its wholly owned subsidiary Orexigen Therapeutics Ireland Ltd.
Orexigen Therapeutics Announces Commercialization and Distributorship ...
8, 2016 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that Valeant Pharmaceuticals International, Inc. (Valeant), through a wholly owned subsidiary, will commercialize Contrave´┐Ż (naltrexone HCl / bupropion HCl extended ...
Orexigen Therapeutics to Present at the 35th Annual JP Morgan Healthcare ...
SAN DIEGO, Dec. 19, 2016 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that the company will present at the 35th Annual J.P. Morgan Healthcare Conference 2017 in San Francisco. The presentation is scheduled for ...